Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FSY50
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $88,739
Award facts
- Contract value 100% obligated
- $88,738.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $88,738.56 to DMS Pharmaceutical Group Inc. for the supply of Keytruda 100 mg/4 ml vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge location with an ultimate completion date of July 10, 2025. This delivery order was issued without a set-aside designation and represents a single product line requisition under the company's broader pharmaceutical supply agreement with the Defense Logistics Agency.
This award is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Keytruda, an oncology therapeutic, is consistent with the company's contract portfolio that spans prescription medications, biologics, and specialty pharmaceutical products. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has maintained a robust history of delivery orders from the Defense Logistics Agency covering an extensive array of medical products supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FSY50?
SPE2DB25FSY50 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 17, 2025.
How much is contract SPE2DB25FSY50 worth?
The government has obligated $88,739 on SPE2DB25FSY50.
Is contract SPE2DB25FSY50 an order under another contract?
Yes. SPE2DB25FSY50 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSY50 competed?
The extent of competition for SPE2DB25FSY50 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award